medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2024, Number 04

<< Back Next >>

Ginecol Obstet Mex 2024; 92 (04)

Incidence of the placental accretism spectrum in the obstetric intensive care unit of the Hospital de la Mujer of Sinaloa

Hernández LEA, Castro AFJ, Morgan OF, Heusinkveld JM, Magaña OD, Peña GGM, Terán CE, Canizalez RA, Murillo LJ, Cortez HJA, Lelevier DAH, Favela HCE, Sandoval QPA, Gámez MAH, Mora PCE, Romero QJG, González QP, Espero CMA

Language: Spanish
References: 19
Page: 137-144
PDF size: 193.13 Kb.


ABSTRACT

Objective: To determine the incidence of placental accretism spectrum in pregnant women admitted to the obstetric intensive care unit of the Hospital de la Mujer, Culiacán, Sinaloa.
Materials and Methods: Retrospective, cross-sectional, descriptive study based on the analysis of the database of the Hospital de la Mujer of patients admitted between 2017 and 2020 with a diagnosis of placenta accreta spectrum, referred or diagnosed at the institution and underwent hysterectomy for the complication studied.
Results: Twenty-two patients with a diagnosis of placenta accreta were analysed, giving a prevalence of 0.09%; of these, caesarean section was indicated in 0.2%. 19 of the 22 patients had a history of previous uterine scarring, all with placenta praevia. Mean age was 30.86 ± 4 years. Caesarean section was performed at a mean gestational age of 34 weeks using two surgical techniques. The mean estimated blood loss was 1,947 mL. The most common operative complications were ureteral (n = 2) and bladder (n = 1) injuries. The most common postoperative complication was vesico-uterine fistula (n = 1). The mean length of stay was 2 days in 16 of the 22 patients and 7 days in the remaining 6 patients.
Conclusions: The most important aspect of placenta accreta is early diagnosis, which allows referral to hospital centres with specialists experienced in the management of these cases.


REFERENCES

  1. García-de la Torre JI, González-Cantú G, Rodríguez-Valdéz A, Mujica-Torres A, et al. Acretismo placentariocon abordaje predictivo y preventivo de hemorragiaobstétrica. Ginecol Obstet Mex 2018; 86 (6): 357-67.https://doi.org/10.24245/gom.v86i6.2034.

  2. Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, FoxKA, et al. Placenta accrete: Diagnosis and managementexpert consensus panel. FIGO Classification forthe clinical diagnosis of placenta accreta spectrumdisorders. Int J Gynaecol Obstet 2019; 146 (1): 20-24.https://doi.org/10.1002/ijgo.12761

  3. Gonzalez-Carrillo O, Llantos-Torres CD. Acretismoplacentario en el Instituto Nacional Materno Perinatal(2017). Revista Peruana de Investigación MaternoPerinatal 2017; 6 (2):13-17. https://doi.org/10.33421/inmp.201791

  4. García-de la Torre JI, González-Cantú G, Rodríguez-Valdéz A, Mujica-Torres A, et al. Acretismo placentariocon abordaje predictivo y preventivo de hemorragiaobstétrica. Ginecol Obstet Mex 2018 ;86 (6): 357-67.https://doi.org/10.24245/gom.v86i6.2034

  5. Sánchez-García BF, Corona-Gutiérrez AA, Sánchez-Peña R, Panduro-Barón JG, et al. Acretismo placentarioen el Hospital Civil de Guadalajara Dr. Juan I. Menchaca.Revista Médica MD 2013; 4: 239-44. https://www.medigraphic.com/pdfs/revmed/md-2013/md134f.pdf

  6. Silver RM, Branch DW. Placenta Accreta Spectrum. NEngl J Med 2018; 378 (16): 1529-36. https://doi.org/10.1056/NEJMcp1709324

  7. Faralli I, Del Negro V, Chinè A, Aleksa N, et al. Placentaaccreta Spectrum (PAS) Disorder: Ultrasoundversus magnetic resonance imaging. Diagnostics(Basel) 2022; 12 (11): 2769. https://doi.org/10.3390/diagnostics12112769

  8. Collins SL, Ashcroft A, Braun T, Calda P, et al. Proposalfor standardized ultrasound descriptors of abnormallyinvasive placenta (AIP). Ultrasound Obstet Gynecol2016; 47 (3): 271-75. https://doi.org/10.1002/uog.14952

  9. Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, FoxKA, et al. FIGO Placenta accreta diagnosis and managementexpert consensus panel. FIGO Classificationfor the clinical diagnosis of placenta accreta spectrumdisorders. Int J Gynaecol Obstet 2019; 146 (1): 20-24.https://doi.org/10.1002/ijgo.1276

  10. Bautista-Gómez E, MoralesGarcía V, Hernández-CuevasJ, Calvo-Aguilar O, et al. Una alternativa quirúrgicapara acretismo placentario. Ginecol Obstet Mex 2011;79 (5): 298-302.

  11. Sánchez Péña R, García Padilla FE, Corona GutiérrezAA, Sánchez García BF. Técnica cesárea-histerectomíamodificada para el tratamiento del acretismo plancentario.Ginecol Obstet Mex 2014; 82: 105-110.

  12. Nieto-Calvache AJ, Palacios-Jaraquemada JM, OsananG, Cortes-Charry R, et al. Latin American group for thestudy of placenta accreta spectrum. Lack of experienceis a main cause of maternal death in placenta accretaspectrum patients. Acta Obstet Gynecol Scand 2021;100 (8): 1445-53. https://doi.org/10.1111/aogs.14163

  13. Sentilhes L, Seco A, Azria E, Beucher G, et al. Conservativemanagement or cesarean hysterectomy for placentaaccreta spectrum: the PACCRETA prospective study.Am J Obstet Gynecol 2022; 226 (6): 839.e1-839.e24.https://doi.org/10.1016/j.ajog.2021.12.013

  14. Badr DA, Al Hassan J, Salem Wehbe G, Ramadan MK.Uterine body placenta accreta spectrum: A detailedliterature review. Placenta 2020; 95: 44-52. https://doi.org/10.1016/j.placenta.2020.04.005

  15. Bluth A, Schindelhauer A, Nitzsche K, Wimberger P,et al. Placenta accreta spectrum disorders-experienceof management in a German tertiary perinatal centre.Arch Gynecol Obstet 2021; 303 (6): 1451-60. https://doi.org/10.1007/s00404-020-05875-x.

  16. Concatto NH, Westphalen SS, Vanceta R, Schuch A, etal. Magnetic resonance imaging findings in placentaaccreta spectrum disorders: pictorial essay. Radiol Bras2022; 55 (3): 181-87. https://doi.org/10.1590/0100-3984.2021.0115

  17. Hasegawa J, Tanaka H, Katsuragi S, Sekizawa A, et al.Maternal death exploratory Committee in Japan and theJapan Association of Obstetricians and Gynecologists.Maternal deaths in Japan due to abnormally invasiveplacenta. Int J Gynaecol Obstet 2018; 140 (3): 375-76.https://doi.org/10.1002/ijgo.12368

  18. Collins SL, Alemdar B, van Beekhuizen HJ, Bertholdt C, etal. International Society for Abnormally Invasive Placenta(IS-AIP). Evidence-based guidelines for the managementof abnormally invasive placenta: recommendations fromthe International Society for Abnormally Invasive Placenta.Am J Obstet Gynecol 2019; 220 (6): 511-26.https://doi.org/10.1016/j.ajog.2019.02.054

  19. Allen L, Jauniaux E, Hobson S, Papillon-Smith J, et al.FIGO Placenta accreta diagnosis and management ExpertConsensus Panel. FIGO Consensus Guidelines onplacenta accreta spectrum disorders: Nonconservativesurgical management. Int J Gynaecol Obstet 2018; 140(3): 281-90. https://doi.org/10.1002/ijgo.12409




2020     |     www.medigraphic.com